Siga Technologies (SIGA) Asset Utilization Ratio (2011 - 2025)
Siga Technologies (SIGA) posted Asset Utilization Ratio of 0.74 for Q3 2025, down 0.94% on a QoQ basis from 0.74 in Q2 2025, and down 17.61% year-over-year from 0.9 in Q3 2024.
Siga Technologies (SIGA) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Siga Technologies' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.74 for Q3 2025.
- Quarterly Asset Utilization Ratio fell 17.61% year-over-year to 0.74 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.74 (down 17.61% YoY) and the FY2024 annual result came in at 0.56, down 10.66% from the prior year.
- Asset Utilization Ratio was 0.74 for Q3 2025 at Siga Technologies, down from 0.74 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.18 in Q3 2022 and bottomed at 0.23 in Q3 2023.
- A 5-year average of 0.69 and a median of 0.7 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio surged 639.2% — and 2023, when it plunged 80.65%.
- Siga Technologies' Asset Utilization Ratio stood at 0.76 in 2021, then retreated by 27.29% to 0.55 in 2022, then increased by 22.18% to 0.68 in 2023, then decreased by 6.93% to 0.63 in 2024, then rose by 16.93% to 0.74 in 2025.
- Business Quant data shows SIGA's Asset Utilization Ratio at 0.74 in Q3 2025, 0.74 in Q2 2025, and 0.49 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.74 |
| Jun 30, 2025 | 0.74 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.79 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 1.18 |
| Jun 30, 2022 | 0.86 |
| Mar 31, 2022 | 0.70 |
| Dec 31, 2021 | 0.76 |
| Sep 30, 2021 | 0.42 |
| Jun 30, 2021 | 0.70 |
| Mar 31, 2021 | 0.88 |
| Dec 31, 2020 | 0.86 |